Troubleshooting GuideEvidence-Based Strategies

GLP-1 Weight Plateau: Why It Happens & What to Do

Has your weight loss stalled on Ozempic, Wegovy, or Mounjaro? Plateaus are a normal part of the weight loss journey. This guide explains why they happen, how long they typically last, and evidence-based strategies to break through.

Normal

Plateaus are expected on any weight loss journey

2-8 weeks

Typical plateau duration before weight loss resumes

12-18 mo

When most people reach stable weight on GLP-1s

Is It Really a Plateau?

Before assuming you've hit a plateau, rule out normal weight fluctuations:

Normal Fluctuations
  • 1-2kg day-to-day variation is normal
  • Water retention from sodium, carbs, exercise
  • Menstrual cycle fluctuations (up to 2kg)
  • Constipation from GLP-1 side effects
True Plateau Signs
  • Weight stable for 4+ consecutive weeks
  • No downward trend on weekly averages
  • Measurements also unchanged
  • Clothes not fitting any differently

Tip: Track your weight weekly at the same time (morning, after bathroom, before eating) and look at 4-week trends rather than daily changes. Apps that show weekly averages can help smooth out fluctuations.

Why Weight Loss Plateaus Happen

Plateaus are your body's natural response to weight loss. Here's what's happening biologically:

Metabolic Adaptation

Your body burns fewer calories at a lower weight. A 15kg loss can reduce daily calorie needs by 200-300+ calories.

Muscle Loss

Weight loss often includes some muscle, which burns more calories at rest than fat. This slows metabolism.

Hormonal Changes

Leptin levels drop with weight loss, increasing hunger signals. Ghrelin may increase, promoting appetite.

Medication Tolerance

While not common, some people may develop reduced sensitivity to GLP-1 effects over time.

Lifestyle Drift

Eating and activity habits often gradually shift over months of treatment, even without awareness.

Set Point Theory

Your body may defend a new lower weight as its set point, requiring time to adjust further.

Typical Weight Loss Timeline on GLP-1s

Understanding the normal pattern can help set realistic expectations:

Months 1-4Rapid Loss Phase

Weight loss is typically fastest during dose escalation. Many people lose 5-10% of body weight. The medication effects are novel and appetite suppression is strong.

Months 4-12Steady Loss Phase

Weight loss continues but often slows. You may experience short plateaus that resolve. Most of your total weight loss occurs during this period. Lifestyle habits become more important.

Months 12-18+Plateau/Maintenance Phase

Most people reach a stable weight plateau. This doesn't mean the medication has stopped working - it's still suppressing appetite and providing metabolic benefits. This weight becomes your new stable point while on treatment.

Stay Updated on GLP-1 weight loss tips

Get notified about availability changes, price updates, and new research. Plus receive our free UK medication guide when it launches.

Free guide (coming soon)
Availability alerts
Weekly updates

Strategies to Break Through a Plateau

Here are evidence-based approaches, organised by category:

Medication Adjustments
High

Discuss dose increase

If not at maximum dose, your prescriber may increase it

Medium

Consider switching medications

Some people respond better to different GLP-1 drugs

Low

Review injection technique

Ensure proper administration for maximum absorption

Nutrition Optimisation
High

Increase protein intake

Aim for 1.6g per kg body weight to preserve muscle

High

Track food honestly

Calorie creep is common - logging helps identify it

Medium

Reduce ultra-processed foods

These can promote overconsumption even with GLP-1

Medium

Consider meal timing

Some find time-restricted eating helps

Exercise Modifications
High

Add resistance training

Builds muscle, increases metabolism, essential during weight loss

Medium

Increase daily movement

Non-exercise activity (NEAT) often drops with weight loss

Medium

Try different cardio

HIIT or new activities can challenge your body differently

Recovery & Lifestyle
High

Prioritise sleep

Poor sleep increases hunger hormones and reduces willpower

Medium

Manage stress

Cortisol promotes fat storage and comfort eating

Low

Stay hydrated

Dehydration can be mistaken for hunger

Dose Considerations

If lifestyle adjustments don't help, medication adjustments may be appropriate:

Increasing Your Dose

If you're not at the maximum dose, increasing may restart weight loss. Discuss with your prescriber about:

  • Whether you're at your maximum tolerated dose
  • If side effects are manageable enough to increase
  • The appropriate next step in the escalation schedule

Maximum Dose Options

MedicationMaximum Dose
Wegovy (semaglutide)2.4mg weekly
Ozempic (semaglutide)1mg weekly (2mg in some countries)
Mounjaro (tirzepatide)15mg weekly
Saxenda (liraglutide)3mg daily

When to Consider Switching Medications

If you've tried optimising your current treatment and plateau persists, switching medications may help:

Consider Switching If:
  • On maximum tolerated dose for 3+ months
  • Lifestyle factors have been optimised
  • Weight loss goals not achieved
  • Intolerable side effects limiting dose
Keep in Mind:
  • Switching isn't guaranteed to work
  • May need to restart dose escalation
  • Side effects may return initially
  • Cost/availability may differ

Read our complete guide to switching GLP-1 medications →

Accepting a New Stable Weight

Sometimes a plateau represents your new stable weight. This is worth considering if:

  • You've lost a significant amount of weight (10%+ of starting weight)
  • You're on the maximum tolerated dose
  • Weight-related health markers have improved (blood pressure, blood sugar, etc.)
  • Further restriction would require unsustainable lifestyle changes
  • You're eating a healthy, balanced diet

Important: A 10-15% weight loss, even if not your original goal, provides significant health benefits and is considered clinically meaningful. Not everyone will achieve the average trial results.

Frequently Asked Questions

Related Guides

References & Sources

  • Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM 2021.
  • Hall KD, et al. Quantification of the effect of energy imbalance on bodyweight. Lancet 2011.
  • Rosenbaum M, et al. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr 2008.
  • NICE Clinical Guideline: Obesity: identification, assessment and management (CG189).

Medical Disclaimer

This information is provided for educational purposes only and is not intended as medical advice. Any changes to your medication regimen should be discussed with your prescriber. If you're concerned about your weight loss progress, consult with your healthcare provider.

Last updated: December 2025

Stay Updated on GLP-1 medication tips

Get notified about availability changes, price updates, and new research. Plus receive our free UK medication guide when it launches.

Free guide (coming soon)
Availability alerts
Weekly updates